Swiss pharmaceutical group Sandoz on Monday announced two amicable settlements in the United States, totalling $478.5 million, to resolve a long-running dispute related to generic drug pricing.

Sandoz pagará US$ 450 milhões para encerrar litígios antitruste nos EUA

Swiss pharma firm Sandoz will pay $478.5M to settle US generic drug price-fixing claims while denying wrongdoing.